GlassScriptPhysician profile
Mudassar Khan
NPI 1386098440
$12,097.77
in general payments reported to CMS, 2019-2025
8 companies · $3,595 in 2025
The $3,595 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $138 · 2021: $2,740 · 2022: $2,689 · 2023: $658 · 2024: $1,827 · 2025: $3,595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,687 · Travel and Lodging: $2,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,686.80 |
| Travel and Lodging | $2,394.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,258.90 | 2019-2025 | Pro, Pangea, Gamma |
| Depuy Synthes Sales INC. | $2,515.51 | 2023-2025 | Na, Tfn-Advance, Va-Lcp |
| Medical Device Business Services, INC. | $1,654.98 | 2019-2024 | Va-Lcp |
| Next Science LLC | $347.30 | 2021 | |
| Smith+Nephew, INC. | $147.67 | 2021-2023 | Stravix |
| Pacira Therapeutics, INC. | $89.28 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $68.50 | 2019 | |
| Biocomposites INC | $15.63 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mudassar Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.